METHODS OF MAKING CHIMERIC ANTIGEN RECEPTOR-EXPRESSING CELLS
This disclosure provides methods of making immune effector cells (for example, T cells, NK cells) that comprise (i) a nucleic acid molecule that encodes a controllable chimeric antigen receptor (CCAR) or (ii) a nucleic acid molecule that encodes a CAR and a regulatory molecule, and compositions gene...
Saved in:
Main Authors | , , , , , , , , , , , , , , , , , |
---|---|
Format | Patent |
Language | English Spanish |
Published |
23.09.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | This disclosure provides methods of making immune effector cells (for example, T cells, NK cells) that comprise (i) a nucleic acid molecule that encodes a controllable chimeric antigen receptor (CCAR) or (ii) a nucleic acid molecule that encodes a CAR and a regulatory molecule, and compositions generated by such methods.
La presente divulgación proporciona métodos para producir células efectoras inmunitarias (por ejemplo, células T, células NK) que comprenden (i) una molécula de ácido nucleico que codifica un receptor de antígeno quimérico controlable (CCAR) o (ii) una molécula de ácido nucleico que codifica un CAR y una molécula reguladora, y composiciones generadas por dichos métodos. |
---|---|
Bibliography: | Application Number: MX20220010685 |